News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,697 Results
Type
Article (39690)
Company Profile (247)
Press Release (658760)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204171)
Career Advice (2007)
Deals (35420)
Drug Delivery (95)
Drug Development (81044)
Employer Resources (172)
FDA (16180)
Job Trends (14858)
News (345189)
Policy (32536)
Tag
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49430)
ALS (88)
Alzheimer's disease (1377)
Antibody-drug conjugate (ADC) (124)
Approvals (16185)
Artificial intelligence (252)
Autoimmune disease (21)
Automation (16)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (278)
Cancer (2250)
Cardiovascular disease (173)
Career advice (1676)
Career pathing (30)
CAR-T (150)
Cell therapy (421)
Cervical cancer (19)
Clinical research (65978)
Collaboration (832)
Compensation (524)
Complete response letters (19)
COVID-19 (2588)
CRISPR (40)
C-suite (240)
Cystic fibrosis (100)
Data (2195)
Decentralized trials (2)
Denatured (18)
Depression (42)
Diabetes (270)
Diagnostics (6367)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86589)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (112365)
Executive appointments (722)
FDA (17426)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (746)
Gene editing (104)
Generative AI (19)
Gene therapy (301)
GLP-1 (707)
Government (4415)
Grass and pollen (4)
Guidances (59)
Healthcare (18814)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (115)
Indications (29)
Infectious disease (2730)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16507)
IRA (40)
Job creations (3631)
Job search strategy (1422)
Kidney cancer (10)
Labor market (38)
Layoffs (467)
Leadership (17)
Legal (7909)
Liver cancer (75)
Lung cancer (320)
Lymphoma (153)
Machine learning (7)
Management (58)
Manufacturing (303)
MASH (66)
Medical device (13375)
Medtech (13380)
Mergers & acquisitions (19455)
Metabolic disorders (682)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1909)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Northern California (2666)
Now hiring (39)
Obesity (362)
Opinion (204)
Ovarian cancer (75)
Pain (85)
Pancreatic cancer (83)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (110)
Peanut (46)
People (57299)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20552)
Phase II (29054)
Phase III (21647)
Pipeline (1184)
Policy (138)
Postmarket research (2563)
Preclinical (8738)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5907)
Recruiting (65)
Regulatory (22270)
Reports (46)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (68)
Series A (129)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2287)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3576)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (39)
The Weekly (29)
United States (23002)
Vaccines (685)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (16)
Date
Today (162)
Last 7 days (849)
Last 30 days (2617)
Last 365 days (32847)
2025 (10577)
2024 (35219)
2023 (40076)
2022 (51175)
2021 (55712)
2020 (54083)
2019 (46538)
2018 (35019)
2017 (32111)
2016 (31480)
2015 (37554)
2014 (31321)
2013 (26348)
2012 (28570)
2011 (29263)
2010 (27329)
Location
Africa (718)
Alabama (53)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (37836)
Australia (6184)
California (6098)
Canada (2008)
China (520)
Colorado (265)
Connecticut (272)
Delaware (146)
Europe (81229)
Florida (906)
Georgia (205)
Idaho (57)
Illinois (532)
India (25)
Indiana (306)
Iowa (11)
Japan (161)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (886)
Massachusetts (4548)
Michigan (219)
Minnesota (389)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1719)
New Mexico (28)
New York (1735)
North Carolina (963)
North Dakota (8)
Northern California (2666)
Ohio (203)
Oklahoma (14)
Oregon (34)
Pennsylvania (1371)
Puerto Rico (12)
Rhode Island (33)
South America (1096)
South Carolina (22)
South Dakota (1)
Southern California (2287)
Tennessee (101)
Texas (903)
Utah (180)
Virginia (144)
Washington D.C. (61)
Washington State (549)
West Virginia (3)
Wisconsin (53)
698,697 Results for "perkinelmer inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PerkinElmer Acquires Project Farma, Expanding Its OneSource Professional Services Offering for the Life Sciences Industry
March 11, 2025
·
3 min read
Deals
PerkinElmer Acquires Covaris to Create an Innovation-Led, Global Life-Sciences and Diagnostics Platform
PerkinElmer today announced that it has acquired Covaris, a leading developer of solutions to empower life science innovations.
December 4, 2023
·
4 min read
Business
PerkinElmer Board Declares Quarterly Dividend - April 25, 2023
The Board of Directors of PerkinElmer, Inc. declared a regular quarterly dividend of $0.07 per share of common stock.
April 25, 2023
·
1 min read
Business
PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023
PerkinElmer Inc. (NYSE: PKI), today announced that it will release its first quarter 2023 financial results prior to market open on Thursday, May 11, 2023.
April 12, 2023
·
1 min read
Business
PerkinElmer Board Declares Quarterly Dividend - Jan 26, 2023
The Board of Directors of PerkinElmer, Inc. declared a regular quarterly dividend of $0.07 per share of common stock.
January 26, 2023
·
1 min read
Genetown
PerkinElmer to Present at Upcoming Investor Conferences - February 22, 2023
PerkinElmer Inc. , (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Cowen 43rd Annual Health Care Conference and the Barclays Global Healthcare Conference.
February 22, 2023
·
1 min read
Press Releases
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
May 1, 2025
·
7 min read
Genetown
PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
PerkinElmer Inc. today announced that the Company will present at the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023 at 2:15 p.m. ET.
March 9, 2023
·
1 min read
Press Releases
RxSight, Inc. to Present at the Bank of America Healthcare Conference
May 1, 2025
·
1 min read
Press Releases
Innovative Lab Services LLC Acquires Compco Analytical, Inc.
May 1, 2025
·
1 min read
1 of 69,870
Next
